U.S. FDA Approved GSK’s Hibsago (bepirovirsen) for treatment of chronic hepatitis B
On Oct. 20, 2026, GSK announced that the U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen)…
-
-
Biotechnology | CDC | Infectious Disease | NIH | Vaccine | WHO
Danish university places hold on controversial U.S. CDC hepatitis B vaccine study in Guinea-Bissau
On Mar. 19, 2026, the University of Southern Denmark announced it has placed a “full hold” on a…
-
Biotechnology | CDC | Infectious Disease | Plague | Vaccine | WHO
WHO Issued statement criticizing Ethics of CDC-funded study of hepatitis B vaccine in Guinea-Bissau
On Feb. 13, 2026, the World Health Organization (WHO) underscores that the hepatitis B birth dose vaccine is…
